Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Benzenesulfonamide, 3,4-dimethoxy-N-(2-cyanoethyl)-N-tetrahydrofurfury l- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

185299-49-4

Post Buying Request

185299-49-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • Benzenesulfonamide, 3,4-dimethoxy-N-(2-cyanoethyl)-N-tetrahydrofurfury l-

    Cas No: 185299-49-4

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier

185299-49-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 185299-49-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,5,2,9 and 9 respectively; the second part has 2 digits, 4 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 185299-49:
(8*1)+(7*8)+(6*5)+(5*2)+(4*9)+(3*9)+(2*4)+(1*9)=184
184 % 10 = 4
So 185299-49-4 is a valid CAS Registry Number.

185299-49-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Benzenesulfonamide, 3,4-dimethoxy-N-(2-cyanoethyl)-N-tetrahydrofurfury l-

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:185299-49-4 SDS

185299-49-4Downstream Products

185299-49-4Relevant articles and documents

Aryl sulfonamides as selective PDE4 inhibitors

Montana, John G.,Buckley, George M.,Cooper, Nicola,Dyke, Hazel J.,Gowers, Lewis,Gregory, Joanna P.,Hellewell, Paul G.,Kendall, Hannah J.,Lowe, Christopher,Maxey, Robert,Miotla, Jadwiga,Naylor, Robert J.,Runcie, Karen A.,Tuladhar, Bishwa,Warneck, Julie B. H.

, p. 2635 - 2640 (2007/10/03)

A series of novel selective phosphodiesterase 4 (PDE4) inhibitors has been developed which displays activity both in vitro and in vivo. These compounds possess good selectivity for the catalytic site of PDE4 over the high affinity Rolipram binding site. In vivo studies demonstrate a reduced propensity to display the emetic side effects which are commonly observed with PDE4 inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 185299-49-4